Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Regencell Bioscience Holdings Limited (RGC) had Cash Flow from Financial Activities of $16.95M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$14.22M |
|
$1.07M |
|
$1.15M |
|
$14.73M |
|
$1.32M |
|
-- |
|
-- |
|
$1.38M |
|
$13.35M |
|
$13.35M |
|
$13.35M |
|
-- |
|
| Cash Flow Statement Financials | |
$-7.70M |
|
$2.50M |
|
|
Cash Flow from Financial Activities |
$16.95M |
$2.42M |
|
$14.19M |
|
$11.77M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|